Last reviewed · How we verify
NCT06982573
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD
NA trial testing Effects of applying magnetic stimulation in End-Stage Renal Disease in 18 participants. Currently enrolling.
19 February 2026
Quick facts
| Lead sponsor | Bundang CHA Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 18 |
| Start date | 6 August 2025 |
| Primary completion | 19 February 2026 |
| Estimated completion | 19 February 2026 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Effects of applying magnetic stimulation
Conditions studied
- End-Stage Renal Disease — all drugs for End-Stage Renal Disease →
Sponsor
Bundang CHA Hospital
Who can join
19 and older, any sex, with End-Stage Renal Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06982573
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for End-Stage Renal Disease
Currently open trials in the same condition.
- NCT07348237 — A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) · Phase 1 · recruiting
- NCT07053462 — CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk · Phase 1, PHASE2 · recruiting
- NCT06224140 — Heparin-Free Chronic HemoDialysis Assessment · NA · recruiting
- NCT05931276 — CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes · Phase 3 · recruiting
- NCT05880537 — Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry · recruiting
Other Bundang CHA Hospital trials
Trials by the same sponsor.
- NCT07366554 — Epigenetic Factors of Colorectal Adenoma in Korean · not yet recruiting
- NCT06982586 — A Prospective, Single-Center, Single-Arm, Investigator-Initiated Exploratory Clinical Trial to Assess the Safety of Repe · NA · not yet recruiting
- NCT06995274 — Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study · NA · not yet recruiting
- NCT06543797 — A Pilot Clinical Trial Study to Determine the Safety of the Application of a Wearable Medical Electromagnetic Generator · EARLY_PHASE1 · not yet recruiting
- NCT06339359 — A Pilot Study to Develop a Behavior-based Screening Protocol for Early Diagnosis of Autism Spectrum Disorders · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06982573 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bundang CHA Hospital
- Last refreshed: 19 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06982573.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing